Guggenheim reaffirmed its purchase of GeneDx in late October and raised the price target to $170 after outperforming the third quarter
GeneDx Holdings Corp. (NASDAQ:WGS) is one of the The best digital health stocks to buy now. On October 29, 2025, Guggenheim raised GeneDx (NASDAQ:WGS) to a price target of $170 (Buy) following the company’s dramatic third-quarter announcement a day earlier. GeneDx had just reported revenue of $116.7 million, up 52% ​​year-over-year and roughly ~12% ahead…